“…Fernandes et al [45] confirmed these data, showing that a lower percentage of small bowel CD patients achieving transmural healing required surgery, hospital admission, and therapy escalation (0%, 3%, and 15.2%, respectively) compared to patients with endoscopic mucosal healing (11.5%, 17.3%, and 36.5%, respectively) or active disease (11.6%, 24%, and 54.3%, respectively) after 12 months of follow-up [45]. Interestingly, both the MRE characteristics (proximal bowel dilatation ≥30 mm diameter (OR: 2.98; 95% CI: 1.36-6.55), stricture bowel wall thickness ≥10 mm (OR: 2.42; 95% CI: 1.11-5.27), and stricture length >5 cm (OR: 2.56; 95% CI: 1.21-5.43)) [46], as well as the disease pathways diagnosed using MRE (presence of perianal disease (OR: 9, 95% CI: 2-39, p = 0.003), stenoses (OR: 3.4, 95% CI: 1-11, p = 0.04), or intra-abdominal fistulas (OR: 10.6, 95% CI: 2-46, p = 0.002)) [47], were significantly related with a higher risk of surgery. A study by Deepak et al [48] investigated the natural history of CD patients managed through a strategy of treating to a target of radiological transmural remission along with a median follow-up of almost 5 years.…”